ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Regencell Bioscience Holdings Limited (RGC), where investors who purchased securities between October 28, 2024 and October 31, 2025 may be entitled to compensation. The lawsuit alleges that Regencell made false statements and failed to disclose vulnerabilities to market manipulation and regulatory risks. The lead plaintiff deadline is June 23, 2026.